Nothing Special   »   [go: up one dir, main page]

Wang et al., 1998 - Google Patents

CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120

Wang et al., 1998

View HTML @Full View
Document ID
17348729656290702349
Author
Wang W
Dudek T
Zhao Y
Brumblay H
Essex M
Lee T
Publication year
Publication venue
Proceedings of the National Academy of Sciences

External Links

Snippet

The seven-transmembrane CCR5 was recently found to double as a coreceptor for a genetically diverse family of human and nonhuman primate lentiviruses. Paradoxically, the main region of the envelope protein believed to be involved in CCR5 utilization was mapped …
Continue reading at www.pnas.org (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Similar Documents

Publication Publication Date Title
Wang et al. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120
Hoffman et al. HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
Dunfee et al. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia
Chabot et al. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates
Zhang et al. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
Tokunaga et al. Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates
Lin et al. A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
Edinger et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain
Lu et al. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
Edinger et al. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
Owen et al. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry
Kolchinsky et al. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops
Gorry et al. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate
Hung et al. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization
Zhang et al. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1
Sullivan et al. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies
Trkola et al. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
Hofmann et al. Species-specific, postentry barriers to primate immunodeficiency virus infection
Kootstra et al. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells
Kolchinsky et al. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication
Picard et al. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion
Harouse et al. CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques
Goodenow et al. HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes
Edinger et al. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains
Pizzato MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1